Medical Research Agency, Poland
Medical Research Agency, Poland
Explore linked clinical trials.33 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Noradrenaline Versus Standard Blood Pressure Management for Perioperative Hypotension in Non-cardiac Surgery | cardiovascular disorder, hypotensive disorder, vascular disorder | Recruiting | Phase 3 | 2026-09-23 | NCT06885268 | |
| Optimal PeriproCeduraL AnticOagulation in Structural Transseptal Interventions | Arrhythmias, Cardiac, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrial fibrillation, cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Enrolling by invitation | Phase 4 | 2026-09-17 | NCT05305612 | |
| Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma. | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 2 | 2026-08-06 | NCT07748689 | |
| A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasm, Residual, Neoplasms by Histologic Type, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Not yet recruiting | Phase 3 | 2026-07-31 | NCT07740486 | |
| Treatment of Presymptomatic (Stage 1) Type 1 Diabetes Pediatric Patients With Treg Cell Preparations and Anti-CD20 Antibody | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, prediabetes syndrome, type 1 diabetes mellitus | Recruiting | Phase 2 | 2026-07-17 | NCT06688331 | |
| Comparing High and lOw-dose asPirin With Dual anTIplatelet Therapy for Three Months Using prasUgrel and aSpirin Following Coronary Artery Bypass Grafting. (OPTIMUS-CABG Trial) | Chronic Coronary Syndrome; Stable Coronary Artery Disease CAD | Recruiting | Phase 3 | 2026-07-14 | NCT07195149 | |
| TTFields Plus FET-PET-Guided Stereotactic Radiosurgery Versus TTFields Alone for Recurrent Glioblastoma (Tarrget 2.0) | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor, syndromic X-linked intellectual disability Snyder type | Recruiting | Not applicable | 2026-06-25 | NCT07668869 | |
| Empagliflozin in the Prevention of Cardiotoxicity in Cancer Patients Undergoing Chemotherapy Based on Anthracyclines | Cardiotoxicity, Chemically-Induced Disorders, Drug-Related Side Effects and Adverse Reactions, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cardiovascular disorder, heart disorder, injury, radiation injury | Active, not recruiting | Phase 3 | 2026-06-16 | NCT05271162 | |
| Atorvastatin Effect on Reduction of COPD Exacerbations | Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, chronic obstructive pulmonary disease, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Phase 4 | 2026-04-21 | NCT04789057 | |
| Application of FET-PET in Fusion With MRI in the Treatment of Glioblastoma Multiforme [TYR-GLIO] | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, glioblastoma, glioma, neoplasm, nervous system disorder, neuroepithelial neoplasm, primitive neuroectodermal tumor | Recruiting | Not applicable | 2026-04-17 | NCT06466031 | |
| Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome | Bone Diseases, Developmental, SAPHO syndrome, bone disorder, musculoskeletal system disorder, osteochondrodysplasia | Recruiting | Phase 2 / Phase 3 | 2026-04-13 | NCT06011889 | |
| Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease | Skin and Connective Tissue Diseases, connective tissue disorder, interstitial lung disease, lung disorder, respiratory system disorder, skin disorder, systemic sclerosis | Recruiting | Phase 3 | 2026-04-08 | NCT06297096 | |
| Study of the Effectiveness of Treatment of Sarcopenia With the Use of a Medicinal Product (Nandrolone), Comprehensive Physiotherapy and Diet | Atrophy, Neurologic Manifestations, Neuromuscular Manifestations, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder | Recruiting | Phase 2 | 2026-04-08 | NCT05978206 | |
| Antegrade Dissection and Re-entry Versus Retrograde Strategy in CTO PCI | Arterial Occlusive Diseases, Coronary Occlusion, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Recruiting | Not applicable | 2026-01-02 | NCT06878729 | |
| LN-RADS, RECIST 1.1 and Node-RADS Classification in the Assessment of Lymph Nodes | Disease Attributes, Hemic and Lymphatic Diseases, Lymph Node Metastasis, Lymphadenopathy, Lymphatic Metastasis, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, lymph node neoplasm, lymphatic system disorder, neoplasm | Recruiting | Not applicable | 2025-12-30 | NCT06527027 | |
| Carbon Fiber Transpedicular Screws in Treatment of Spinal Metastatic Disease | Spinal Cord Compression, bone disorder, central nervous system disorder, injury, musculoskeletal system disorder, nervous system disorder, spinal cord disorder, spinal cord injury, vertebral column disorder | Recruiting | Not applicable | 2025-12-16 | NCT06293157 | |
| Anti-atherosclerotic Efficacy of Selected Antidiabetic Drugs in Patients With Coronary Artery Disease and Pre-diabetes | Arterial Occlusive Diseases, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, diabetes mellitus, endocrine system disorder, glucose metabolism disease, heart disorder, metabolic disease, myocardial ischemia, prediabetes syndrome, vascular disorder | Recruiting | Phase 4 | 2025-11-28 | NCT07254572 | |
| Comparison of Three Interventions for Antibiotic-Resistant Bacteria (ARB) Decolonization From the Gastrointestinal Tract | Antimicrobial Drug Resistance; Drug Resistance, Bacterial | Recruiting | Not applicable | 2025-09-03 | NCT07094984 | |
| Radiotherapy Strategies for Use in Combined Treatment of Small-cell Lung Cancer | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Not applicable | 2025-08-28 | NCT06529081 | |
| Portal Inflow Modulation Prior to Liver Transplantation in Patients With Increased Risk of Intraoperative Blood Loss | Digestive System Diseases, Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liver, liver disorder | Recruiting | Not applicable | 2025-08-08 | NCT07111221 | |
| Subthreshold Micropulse Laser Therapy (SML) in Retinitis Pigmentosa | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa | Enrolling by invitation | Not applicable | 2025-07-31 | NCT07088705 | |
| Early Supplementation for Cow's Milk Allergy Prevention | Cow's Milk Allergy, Hypersensitivity, Immediate, Milk Hypersensitivity, food allergy, immune system disorder | Not yet recruiting | Not applicable | 2025-07-17 | NCT06652698 | |
| Oritavancin for CIED Infections With MDR Gram-positive Cocci | Bacterial Infections and Mycoses, Disease Attributes, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bacterial infectious disease, cardiovascular disorder, endocarditis, gram-positive bacterial infections, heart disorder, iatrogenic disease, infective endocarditis, nosocomial infection | Not yet recruiting | Not applicable | 2025-06-10 | NCT07013552 | |
| Physiologic Cardiac Pacing to Prevent Left Ventricular Dysfunction Post TAVI | Arrhythmias, Cardiac, Bradycardia, Cardiac Conduction System Disease, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, atrioventricular block, atrioventricular dissociation, cardiovascular disorder, heart disorder, heart failure, neoplasm | Recruiting | Not applicable | 2025-06-08 | NCT05966675 | |
| ctDNA Monitoring in Patients With HCC and mCRC | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Not applicable | 2025-06-03 | NCT07001085 |